Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Top Cited Papers
Open Access
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 149 (3), 649-659
- https://doi.org/10.1053/j.gastro.2015.05.010
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- OPTN/SRTR 2012 Annual Data Report: LiverAmerican Journal of Transplantation, 2014
- Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶Hepatology, 2010
- Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced FibrosisAnnals of Internal Medicine, 2007
- Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term resultsLiver Transplantation, 2007
- Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipientsAlimentary Pharmacology & Therapeutics, 2005
- Long-term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK liver transplantation databaseLiver Transplantation, 2004
- Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre- and Post-Liver Transplantation PatientsHepatology, 2003
- Evolution of liver transplantation in Europe: Report of the European Liver Transplant RegistryLiver Transplantation, 2003
- Model for end-stage liver disease (MELD) and allocation of donor liversGastroenterology, 2003
- Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantationHepatology, 2000